Dominic Tyer
@dominic-tyer.bsky.social
đ€ 489
đ„ 1233
đ 407
Senior Editor | GlobalData Healthcare
https://www.globaldata.com/industries/pharmaceutical
Telix opens radiopharmaceutical facility, combining radiochemistry laboratories, clinical manufacturing, patient dose administration and imaging, in Australia for cancer treatment
www.pharmaceutical-technology.com/news/telix-r...
#pharma
#manufacturing
loading . . .
Telix opens radiopharmaceutical facility in Australia for cancer treatment
Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments.
https://www.pharmaceutical-technology.com/news/telix-radiopharmaceutical-facility-australia/?cf-view
about 6 hours ago
0
0
1
reposted by
Dominic Tyer
Duncan Weldon
1 day ago
This is a mess.
www.bbc.co.uk/news/article...
loading . . .
Midnight social media curfew proposed for older UK teens
The government says it will improve teenagers' lives but campaigners call it a "missed opportunity".
https://www.bbc.co.uk/news/articles/c982857nlrlo
4
27
3
This is not, unfortunately, how a good news press release is headlined. Suspect this bit would inform the lede: "61 disease components across 35 countries and three multi-countries will transition out of Global Fund support in GC8 and 21 disease components in 12 countries in Grant Cycle 9."
add a skeleton here at some point
1 day ago
0
0
0
Moderna secures a European Commission contract for up to 24 million doses of its RSV vaccine
www.pharmaceutical-technology.com/news/moderna...
#pharma
#vaccines
loading . . .
Moderna secures up to 24 million RSV vaccine dose contract with Europe - Pharmaceutical Technology
Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.
https://www.pharmaceutical-technology.com/news/moderna-secures-up-to-24-million-rsv-vaccine-dose-contract-with-europe/
2 days ago
0
0
0
reposted by
Dominic Tyer
Emily Mullin
2 days ago
Hi! WIRED health reporter here. Looking to speak with people who got sick with cyclosporiasis and are willing to share the gruesome details.
[email protected]
10
176
152
reposted by
Dominic Tyer
Andrew Gregory
2 days ago
UK children will be one of unhealthiest generations in decades, doctors say
loading . . .
UK children will be one of unhealthiest generations in decades, doctors say
Analysis of 12 indicators including asthma, obesity and vaccination finds child health is ânational embarrassmentâ
https://www.theguardian.com/society/2026/jul/14/children-uk-unhealthiest-generation-decades-doctors-say?CMP=Share_iOSApp_Other
2
3
5
reposted by
Dominic Tyer
Reuters Institute
2 days ago
The use of AI chatbots for news has risen in the past year, with 10% using them globally for this purpose. Use is much higher among younger audiences and those most interested in news, writes Amy Ross Arguedas Click to read
loading . . .
Emerging uses of AI chatbots for news and what it means for journalism
The rapid rise of generative AI has become a growing focus for journalism, as publishers and platforms grapple with what it means for how people access and engage with news. Much of the attention hasâŠ
https://buff.ly/oUBXgZ3
0
5
5
Teva Pharmaceuticals and Polpharma Biologics sign a global deal for a biosimilar version of the MS treatment ocrelizumab, with Polpharma retaining
#manufacturing
responsibility
www.pharmaceutical-technology.com/news/teva-po...
#pharma
#biosimilars
loading . . .
Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.
https://www.pharmaceutical-technology.com/news/teva-polpharma-biologics-deal-ocrelizumab-biosimilar/?cf-view&cf-closed
3 days ago
0
0
0
This, but also CDs
add a skeleton here at some point
3 days ago
0
0
1
reposted by
Dominic Tyer
Margot Finn
3 days ago
'Volunteers are being recruited, with the first doses expected to be given to healthy adults in the UK "within weeks".' Early days, but seriously amazing.
loading . . .
UK starts first vaccine trial, eight weeks into Ebola emergency
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
https://www.bbc.co.uk/news/articles/cpwep8xnkrqo
7
137
58
reposted by
Dominic Tyer
Matthew Cobb
6 days ago
Fabulous photo in The TLS. What was the aim of the exercise I wonder? Know your enemy or know yourself?
0
3
1
US-UK pharma trade deal paints a costly economic picture for NHS
www.pharmaceutical-technology.com/news/us-uk-p...
#pharma
loading . . .
US-UK pharma trade deal paints a costly economic picture for NHS - Pharmaceutical Technology
Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions.
https://www.pharmaceutical-technology.com/news/us-uk-pharma-trade-deal-paints-a-costly-economic-picture-for-nhs/?cf-view
9 days ago
0
0
0
reposted by
Dominic Tyer
Adriel Bettelheim
9 days ago
Mapped: Where Obamacare enrollment is plummeting
www.axios.com/newsletters/...
loading . . .
Axios AM - đ©ș Mapped: Obamacare enrollment plummets
https://www.axios.com/newsletters/axios-am-3deea4a6-dcce-4613-b929-33f32c97580c.html?chunk=5&utm_term=emshare#story5
0
1
1
As big tech increasingly eyes biopharma expansion, Anthropic debuts its AI-driven pharma R&D tool Claude Science
www.pharmaceutical-technology.com/news/anthrop...
#pharma
#biotech
#AI
loading . . .
Anthropic debuts AI-driven pharma R&D tool, Claude Science - Pharmaceutical Technology
Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.
https://www.pharmaceutical-technology.com/news/anthropic-launches-claude-science-ai-tool-drug-discovery/
14 days ago
0
0
0
reposted by
Dominic Tyer
KFF
15 days ago
Exposure to these four false vaccine claims has been fairly steady in KFF polls over the past several years. While few people think these myths are definitely true, at least half of adults express some uncertainty â saying the false claims are âprobably trueâ or âprobably false.â
1
4
7
reposted by
Dominic Tyer
Colette Delawalla, PhD
15 days ago
This is a REALLY important story to tell: actually trust in science is quite high overall. It is dropping with Republicans and that is due to a self-sorting phenomenon that is causing one group to have low trust IN THE ESTABLISHMENT ACROSS THE BOARD.
www.nature.com/articles/d41...
loading . . .
Have people stopped trusting science? The data tell a surprising story
Some say thereâs a global crisis of trust â but research reveals where the real problems lie.
https://www.nature.com/articles/d41586-026-01977-9
6
89
35
Investors at BIO 2026 say lost life sciences investment has left the US vulnerable, while China fosters a future generation of big pharma competitors.
www.pharmaceutical-technology.com/news/bio-202...
#pharma
#biotech
#BIO2026
loading . . .
BIO 2026: How NIH cuts have threatened US competitiveness against China - Pharmaceutical Technology
Investors at BIO 2026 say lost life sciences investment has left the US vulnerable while China fosters future big pharma competitors.
https://www.pharmaceutical-technology.com/news/bio-2026-how-nih-cuts-have-threatened-us-competitiveness-against-china/
21 days ago
0
1
0
The stakes are high for US states as the drive to onshore biopharma manufacturing yields billions of dollars of industry investment. Indiana is one of those at BIO 2026 looking to differentiate itself.
www.pharmaceutical-technology.com/analyst-comm...
#pharma
#biotech
#BIO2026
#Indiana
loading . . .
BIO 2026: Indiana, biopharma investment and the Lilly effect - Pharmaceutical Technology
BioCrossroads' Vince Wong discusses how his state is looking to differentiate itself from its rivals.
https://www.pharmaceutical-technology.com/analyst-comment/bio-2026-indiana-biopharma-investment-and-the-lilly-effect/?cf-view
21 days ago
1
0
0
BIO 2026: NVIDIA unveils its BioNeMo toolkit for AI agents in R&D
www.pharmaceutical-technology.com/news/bio-202...
#BIO
#BIO2026
loading . . .
BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents - Pharmaceutical Technology
The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.
https://www.pharmaceutical-technology.com/news/bio-2026-nvidia-announces-the-bionemo-toolkit-for-ai-agents/
23 days ago
0
1
0
BIO 2026: Drug manufacturers band together to tackle employment challenges, jointly sponsoring efforts to attract new talent amid onshoring
www.pharmaceutical-technology.com/news/bio-202...
#pharma
#BIO
#BIO2026
loading . . .
BIO 2026: Drug manufacturers band together to tackle employment challenges - Pharmaceutical Technology
US manufacturers defy the tragedy of the commons by jointly sponsoring efforts to attract new talent amid onshoring.
https://www.pharmaceutical-technology.com/news/bio-2026-drug-manufacturers-band-together-to-tackle-employment-challenges/?cf-view
23 days ago
0
0
0
Biopharma industry confidence at highest in years despite geopolitical headwinds
www.pharmaceutical-technology.com/news/biophar...
#pharma
#biotech
loading . . .
Biopharma industry confidence at highest in years despite geopolitical headwinds - Pharmaceutical Technology
GlobalData says that the industry has âabsorbed significant disruptionâ, with high M&A levels testament to recovery.
https://www.pharmaceutical-technology.com/news/biopharma-industry-confidence-at-highest-in-years-despite-geopolitical-headwinds/
23 days ago
0
0
0
Cell and gene therapy firms outlined their use of AI in biotech manufacturing at BIO 2026, providing some much needed practical examples of how the technology's being used (think: data lakes and streamlined production).
www.pharmaceutical-technology.com/analyst-comm...
#biotech
#manufacturing
loading . . .
BIO 2026: Cell and gene therapy firms outline their use of AI in manufacturing - Pharmaceutical Technology
From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
https://www.pharmaceutical-technology.com/analyst-comment/bio-2026-cell-and-gene-therapy-firms-outline-their-use-of-ai-in-manufacturing/?cf-view
23 days ago
0
1
0
I appear to have come to California from London for BIO to cool down. So if the UK heatwave could leave before I return that would be much appreciated.
23 days ago
0
0
0
reposted by
Dominic Tyer
Simon Kuestenmacher
29 days ago
This made me laugh. Here is a London Tube map of the digestive system. Source:
buff.ly/23pvsjh
15
480
184
FDA and MHRA have forged a new regulatory collaboration that aims to improve the global oversight of medical devices, AI and innovative medicines
www.pharmaceutical-technology.com/news/fda-and...
#pharma
loading . . .
FDA and MHRA forge new regulatory collaboration initiative - Pharmaceutical Technology
The new initiative is intended to improve the global oversight of medical devices, AI, and innovative medicines and to streamline knowledge sharing efforts.
https://www.pharmaceutical-technology.com/news/fda-and-mhra-forge-new-regulatory-collaboration-initiative/
28 days ago
0
0
0
reposted by
Dominic Tyer
Mike Sowden
29 days ago
Zero.
www.bbc.co.uk/news/article...
14
1797
591
reposted by
Dominic Tyer
Margot Finn
about 1 month ago
'Since 2013, central government spending on science and technology in China has nearly doubled. Its 2026 budget includes a 16.3 per cent increase in funding for basic research. Programmes...have turned a small group of Chinese universities into world-class research centres.' 1/3
loading . . .
Understanding where global higher education is heading means understanding Chinaâs next moves
Glen Noble gets across what the Chinese governmentâs recent five-year plan means for international scientific collaboration and UK universities Glen Noble gets across what the Chinese governmentâs rec...
https://wonkhe.com/blogs/understanding-where-global-higher-education-is-heading-means-understanding-chinas-next-moves/
1
6
6
Novo Nordisk comeback stirs as Wegovy pill wins UK approval
www.pharmaceutical-technology.com/news/novo-no...
#pharma
loading . . .
Novo Nordisk comeback stirs as Wegovy pill wins UK approval - Pharmaceutical Technology
There are already lengthy patient waitlists for the medication on digital health platforms.
https://www.pharmaceutical-technology.com/news/novo-nordisk-comeback-stirs-as-wegovy-pill-wins-uk-approval/
about 1 month ago
0
0
0
FDA clears Merck & Co's Keytruda combination (plus Welireg) for ccRCC treatment
www.pharmaceutical-technology.com/news/fda-msd...
#pharma
loading . . .
FDA clears MSDâs Keytruda combo plus Welireg for ccRCC treatment
MSD has received approval from the FDA for both Keytruda and Keytruda Qlex, in combination with Welireg, as an adjuvant treatment for adults with renal ccRCC.
https://www.pharmaceutical-technology.com/news/fda-msd-keytruda-combo-plus-welireg/?cf-view&cf-closed
about 1 month ago
0
0
0
reposted by
Dominic Tyer
Darren Mark Skilton
about 1 month ago
More Disco Less Fascism DJ Norman Cook, aka Fatboy Slim, at the Carnival Against Fascism in Brighton city centre yesterday. The Carnival brought an estimated 4000 people to the streets to oppose a planned hate march by a right-wing group calling themselves 'Patriots'.
2
168
46
reposted by
Dominic Tyer
Jocalyn Clark
about 1 month ago
Great job op to help shape future of journals. Youâd be joining a fantastic group of editors and superb supportive forward thinking colleagues.
add a skeleton here at some point
1
1
2
Parabilis Medicines sets biotech record with $670m IPO
www.pharmaceutical-technology.com/news/parabil...
#biotech
#pharma
loading . . .
Parabilis Medicines sets biotech record with $670m IPO - Pharmaceutical Technology
Parabilisâ US listing means the biotech IPO record has been broken twice in as many months as public listings continue hot streak.
https://www.pharmaceutical-technology.com/news/parabilis-medicines-sets-biotech-record-with-670m-ipo/
about 1 month ago
0
1
0
Claude Fable wonât answer basic biology questions
www.theverge.com/ai-artificia...
loading . . .
Claude Fable is too scared to teach you about the powerhouse of the cell
Good luck asking Anthropicâs Fable about biology.
https://www.theverge.com/ai-artificial-intelligence/947973/fable-wont-answer-basic-biology-questions
about 1 month ago
0
0
0
WuXi AppTec hits back after being named in Pentagonâs Chinese military list, tells Pharmaceutical Technology its inclusion âwas clearly a mistake"
www.pharmaceutical-technology.com/news/wuxi-ap...
#pharma
#CDMO
#CDMOs
#manufacturing
loading . . .
WuXi AppTec hits back after being named in Pentagonâs Chinese military list - Pharmaceutical Technology
A spokesperson for the Chinese company said âwe will take immediate actionâ following the military designation.
https://www.pharmaceutical-technology.com/news/wuxi-apptec-hits-back-after-being-named-in-pentagons-chinese-military-list/?cf-view
about 1 month ago
0
0
0
reposted by
Dominic Tyer
David Henig
about 1 month ago
"Despite widespread nostalgia for manufacturing jobs, new US factories often struggle to find reliable workers" Hey, who'd have thought that young people wouldn't have the same nostalgic fervour as ageing politicians? Maybe we get the economy we want?
www.ft.com/content/e7a3...
loading . . .
What happened to the great rebirth of American manufacturing?
Skills shortages, shifting tariffs and complex permitting processes are major barriers
https://www.ft.com/content/e7a3d4e0-1b83-4dd5-9988-4df3d11bc71a?syn-25a6b1a6=1&emailId=d86cef2f-0128-49c5-a046-86cb6a250cf7&segmentId=7d033110-c776-45bf-e9f2-7c3a03d2dd26
11
72
21
reposted by
Dominic Tyer
Will Jennings
about 1 month ago
www.timeout.com/london/news/...
loading . . .
A major new contemporary arts venue is opening on Londonâs South Bank this month
Itâs just down the road from Tate Modern.
https://www.timeout.com/london/news/a-major-new-contemporary-arts-venue-is-opening-on-londons-south-bank-this-month-061026
2
16
6
As long-standing vulnerabilities in the
#pharma
manufacturing supply chain continue to be accentuated by the Middle East conflict, I took a look at the impact of geopolitics on medicine access đhttps://www.pharmaceutical-technology.com/features/pharma-supply-chain-manufacturing-medicine-access/
about 1 month ago
0
0
0
reposted by
Dominic Tyer
Liz Szabo
about 1 month ago
Really important story. Leaders Resign From ADA After Experts Booted From Meeting
www.medpagetoday.com/special-repo...
loading . . .
Leaders Resign From ADA After Experts Booted From Meeting
Resignations included the organization's president-elect and scientific sessions chair
https://www.medpagetoday.com/special-reports/exclusives/121657
0
22
7
reposted by
Dominic Tyer
Institute of Historical Research
about 1 month ago
Elizabeth Garrett Anderson, the first woman to obtain a formal medical education in Britain, was born on this day in 1836. Through the Bibliography of British and Irish History (BBIH), you can research Anderson and other incredible female pioneers in the history of medicine.
0
47
14
Roche signs $2.3 billion blood cancer drug agreement with Nurix Therapeutics to develop bexobrutideg across B-cell malignancies, immunology and neurology.
www.pharmaceutical-technology.com/news/roche-s...
#pharma
loading . . .
Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics - Pharmaceutical Technology
Roche believes its new BTK-degrader bexobrutideg will outperform approved BTK-inhibitors in B-cell malignancies.
https://www.pharmaceutical-technology.com/news/roche-signs-2-3bn-blood-cancer-drug-agreement-with-nurix-therapeutics/?cf-view
about 1 month ago
0
0
0
Sanofi and Owkin partner to develop next-generation biopharma AI agents to augment drug discovery and development
www.pharmaceutical-technology.com/news/sanofi-...
#pharma
#AI
loading . . .
Sanofi, Owkin partner to develop next-generation biopharma AI agents
Sanofi has entered a multi-year agreement with Paris-based agentic AI company Owkin to co-develop next-generation AI-driven biopharma agents.
https://www.pharmaceutical-technology.com/news/sanofi-owkin-biopharma-ai-agents/
about 1 month ago
0
0
0
reposted by
Dominic Tyer
Theo
about 1 month ago
We live in the stupidest timeline.
91
10094
1586
reposted by
Dominic Tyer
Prof Gavin Yamey
about 1 month ago
We love to see it đđđđ
add a skeleton here at some point
0
53
12
reposted by
Dominic Tyer
Athena Kugblenu
about 1 month ago
We never shut up about it!! And we decided. If you've ever worn a verucca sock in a dilapidated victorian swimming pool, you're British.
add a skeleton here at some point
18
286
40
reposted by
Dominic Tyer
Jonn Elledge
about 1 month ago
This is great. "If you canât be bothered to write it, why should anyone be bothered to read it?" is spot on.
add a skeleton here at some point
16
1044
305
reposted by
Dominic Tyer
Madhu Pai, MD, PhD
about 1 month ago
One is a virus and the other is a flower Beautiful shapes forged by a powerful, relentless force called evolution
0
10
3
Novartis banks on quick manufacturing to find a commercial edge for the CAR-T cell therapy it's co-developing with Legend
www.pharmaceutical-technology.com/analyst-comm...
#pharma
#manufacturing
#ASCO
#ASCO2026
loading . . .
ASCO 2026: Mixed SCLC result for Legendâs LB2102, Novartis expedites manufacture - Pharmaceutical Technology
As Legendâs LB2102 trial in SCLC fails to dazzle, co-developer Novartis banks on quick manufacturing to find a commercial edge.
https://www.pharmaceutical-technology.com/analyst-comment/asco-2026-mixed-sclc-result-for-legends-lb2102-novartis-expedites-manufacture/?cf-view&cf-closed
about 1 month ago
0
0
0
reposted by
Dominic Tyer
David Henig
about 1 month ago
As per The Who, Meet the new US tariffs, same as the old ones... (Different legal basis)
add a skeleton here at some point
1
17
5
FDA approves AstraZenecaâs Imfinzi-BCG combination for NMIBC therapy
www.pharmaceutical-technology.com/news/fda-app...
#pharma
loading . . .
FDA approves AstraZenecaâs Imfinzi-BCG combination for NMIBC therapy
AstraZeneca has secured FDA approval for Imfinzi in combination with BCG induction and maintenance therapy for adults with BCG-naĂŻve, high-risk NMIBC.
https://www.pharmaceutical-technology.com/news/fda-approves-astrazeneca-imfinzi-bcg-combination/
about 1 month ago
0
0
0
Load more
feeds!
log in